文献速递慢病防控与筛查卫生政策与健康促进

筛查糖尿病前期与糖尿病:临床性能及对健康公平的影响

Screening for Prediabetes and Diabetes: Clinical Performance and Implications for Health Equity.
PubMed 文献 · Am J Prev Med · 2023-03-24

研究基于2017年1月至2020年3月美国全国代表性数据(3243名未诊断糖尿病的非孕成人),比较2021与2015年USPSTF筛查标准的临床性能。2021标准灵敏度略高(58.6% vs 52.9%)、特异度较低(69.3% vs 76.4%),筛查所有35-70岁成人(不论BMI)在不同种族和民族间性能最均衡。

要点

  • 2021 USPSTF标准较2015标准灵敏度略高、特异度较低,在各民族中均如此。
  • 更低年龄和BMI阈值可提高灵敏度但降低特异度,尤其在西班牙裔、非西班牙裔黑人和亚裔成人中。
  • 筛查所有35-70岁成人不论BMI性能最公平,可能改善早期检出。

核心结论

  • 2021 USPSTF筛查标准将在所有种族和民族中识别出比2015标准更多的糖尿病前期和糖尿病患者。
  • 筛查所有35-70岁成人表现出更高灵敏度且在不同种族和民族间性能最相似,可能进一步改善早期检出。

研究设计与样本

  • 研究使用2017年1月至2020年3月收集的3243名非孕、未诊断糖尿病的美国成人全国代表性数据,分析于2021至2022年进行。
  • 筛查资格基于年龄和测量的BMI;糖尿病前期和未诊断糖尿病定义为空腹血浆葡萄糖≥100 mg/dL或血红蛋白A1c≥5.7%。

主要发现

  • 2021标准整体灵敏度为58.6%(95%CI=55.5, 61.6),2015标准为52.9%(95%CI=49.7, 56.0)。
  • 2021标准整体特异度为69.3%(95%CI=65.7, 72.2),2015标准为76.4%(95%CI=73.3, 79.2)。
  • 在每个种族和民族组内,2021标准较2015标准灵敏度略高、特异度较低。
  • 更低年龄和BMI阈值导致灵敏度更高、特异度更低,尤其在西班牙裔、非西班牙裔黑人和亚裔成人中。
  • 筛查所有35-70岁成人不论BMI在所有种族和民族组间性能最公平。

关键数值与推荐

  • 2021 USPSTF推荐对35-70岁超重/肥胖的无症状成人筛查糖尿病前期和糖尿病,较2015推荐的40岁降低年龄。
  • USPSTF建议考虑在糖尿病风险高且发病年龄更小或BMI更低的种族和民族群体中更早筛查。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In 2021, the U.S. Preventive Services Task Force (USPSTF) recommended prediabetes and diabetes screening for asymptomatic adults aged 35-70 years with overweight/obesity, lowering the age from 40 years in its 2015 recommendation. The USPSTF suggested considering earlier screening in racial and ethnic groups with high diabetes risk at younger ages or lower BMI. This study examined the clinical performance of these USPSTF screening recommendations as well as alternative age and BMI cutoffs in the U.S. adult population overall, and separately by race and ethnicity. METHODS: Nationally representative data were collected from 3,243 nonpregnant adults without diagnosed diabetes in January 2017-March 2020 and analyzed from 2021 to 2022. Screening eligibility was based on age and measured BMI. Collectively, prediabetes and undiagnosed diabetes were defined by fasting plasma glucose ≥100 mg/dL or hemoglobin A1c ≥5.7%. The sensitivity, specificity, and predictive values of alternate screening criteria were examined overall, and by race and ethnicity. RESULTS: The 2021 criteria exhibited marginally higher sensitivity (58.6%, 95% CI=55.5, 61.6 vs 52.9%, 95% CI=49.7, 56.0) and lower specificity (69.3%, 95% CI=65.7, 72.2 vs 76.4%, 95% CI=73.3, 79.2) than the 2015 criteria overall, and within each racial and ethnic group. Screening at lower age and BMI thresholds resulted in even greater sensitivity and lower specificity, especially among Hispanic, non-Hispanic Black, and Asian adults. Screening all adults aged 35-70 years regardless of BMI yielded the most equitable performance across all racial and ethnic groups. CONCLUSIONS: The 2021 USPSTF screening criteria will identify more adults with prediabetes and diabetes in all racial and ethnic groups than the 2015 criteria. Screening all adults aged 35-70 years exhibited even higher sensitivity and performed most similarly by race and ethnicity, which may further improve early detection of prediabetes and diabetes in diverse populations.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. O'Brien MJ, Zhang Y, Bailey SC, et al. Screening for Prediabetes and Diabetes: Clinical Performance and Implications for Health Equity. Am J Prev Med. 2023. PMID: 37171231. doi:10.1016/j.amepre.2023.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。